HepaLife Technologies Inc.
60 State Street
Suite 700
Boston,
MA 02109
United States - Map
Phone: 800-518-4879
Fax: 604-659-5029
Web Site: http://www.hepalife.com
| HepaLife Technologies, Inc., a development stage biotechnology company, focuses on the development of a cell-based bioartificial liver system. It focuses on developing HepaMate, a cell-based bioartificial liver system, which has completed Phase II/III clinical trials for the treatment of liver failure. The company was formerly known as Zeta Corporation and changed its name to HepaLife Technologies, Inc. in April 2003. HepaLife Technologies was founded in 1997 and is based in Boston, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Amit Singh Dang , 29
Acting Chief Exec. Officer, Pres and Sec. |
N/A
| N/A | Ms. Donna A. Lopolito , 50
Chief Financial Officer |
N/A
| N/A | Dr. Ayesha Mahmood Ph.D,
Member of R&D Work and Member of United States Department of Agriculture Scientist |
N/A
| N/A | Mr. Ryan R. Willard ,
Member of United States Department of Agriculture Scientist |
N/A
| N/A | Dr. Neil C. Talbot ,
Member of United States Department of Agriculture Scientist |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 
Profile
